Guidance: Compounding Animal Drugs from Bulk Drug Substances: Compounding under CGMP in Federally-Registered Facilities
FDA issued guidance on compounding animal drugs from bulk drug substances under CGMP in federally-registered facilities, clarifying requirements for animal drug compounding.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 27, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Compounding pharmacies and facilities that compound animal drugs from bulk drug substances and are registered with the FDA. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline provided; guidance is effective upon publication.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The guidance clarifies the conditions under which animal drugs can be compounded from bulk drug substances, including CGMP requirements for federally-registered facilities.
Who it affects
Compounding pharmacies and facilities that compound animal drugs from bulk drug substances and are registered with the FDA.
What you must do
Review the guidance to ensure your compounding practices align with the clarified requirements, particularly regarding CGMP compliance.
Deadline
No specific deadline provided; guidance is effective upon publication.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Abortion Exceptionalism: How the New Louisiana Law Classifying Medication Abortion as a “Controlled Substance” Compromises Health Care - National Partnership for Women & Families
- Decision and Order: Atlantic Treatment Center, LLC
- NC pharmacists can now dispense birth control without a prescription. How it works. - Raleigh News & Observer
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments